IncFact
Company Profiles: Revenue, Growth, Competition

Brickell Biotech Revenue, Growth & Competitor Profile

DBA FRESH TRACKS THERAPEUTICS, INC.
DBA VICAL INCORPORATED
Last updated:

Company Awards

 
Public Company
public company
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Brickell Biotech

Access the complete profile.

Brickell Biotech Fast Facts

Revenue$10 - $100 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
325414 Biological Product Manufacturing
5417 Scientific Research & Development Services
Address5777 Central Avenue Suite 102
Boulder, CO 80301



Brickell Biotech's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Brickell Biotech is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Brickell Biotech is a publicly traded company on NCM using the ticker symbol VICL. Detailed information on company financials and operating reports can be found here: NCM: VICL



Brickell Biotech Annual Revenue and Growth Rate

Brickell Biotech Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $10 - $100 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Brickell Biotech's revenues are gauged from an analysis of company filings.



Investor Activity

Brickell Biotech has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
June 7, 2022 1 100%$0 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Brickell Biotech is developing and marketing. Brickell Biotech doesn't have any recent trademark applications, indicating Brickell Biotech is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
BRICKELL BIO
Providing medical information from a web site
10/29/2021
FRESH TRACKS
Providing medical information from a web site
10/29/2021

See all trademarks and details in the Full Report.


Market Share of Brickell Biotech's Largest Competitors

A competitive analysis shows these companies are in the same general field as Brickell Biotech, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
XYMOGENOrlando, FL100 
AVANTI NUTRITIONAL LABORATORIESMiami Lakes, FL37 
NUTRITION FORMULATORSMiramar, FL36 
RTPRCabot, AR33 
INTEGRATED BOTANICSFort Worth, TX29 
COSMAX NBT USAGarland, TX29 
CJB INDUSTRIESValdosta, GA28 
ALTERNATIVE LABORATORIESNaples, FL28 
S&B PHARMAAzusa, CA28 




Nearby Competitors

These companies are similar in business line and location to Brickell Biotech. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
CORDEN PHARMA COLORADOBoulder, CO100 
ARRAY BIOPHARMABoulder, CO38 
ENVEDA THERAPEUTICSBoulder, CO35 
DROPWORKSBoulder, CO9 
MATY'S HEALTHY PRODUCTSBoulder, CO3 
BRICKELL BIOTECHBoulder, CO2 




Future Competition: Brickell Biotech's Fastest Growing Competitors

These companies are in the same general field as Brickell Biotech and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Brickell Biotech Competitors